Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality

The Journal of Cell Biology
Fred D MastJohn D Aitchison

Abstract

With the rapid global spread of SARS-CoV-2, we have become acutely aware of the inadequacies of our ability to respond to viral epidemics. Although disrupting the viral life cycle is critical for limiting viral spread and disease, it has proven challenging to develop targeted and selective therapeutics. Synthetic lethality offers a promising but largely unexploited strategy against infectious viral disease; as viruses infect cells, they abnormally alter the cell state, unwittingly exposing new vulnerabilities in the infected cell. Therefore, we propose that effective therapies can be developed to selectively target the virally reconfigured host cell networks that accompany altered cellular states to cripple the host cell that has been converted into a virus factory, thus disrupting the viral life cycle.

References

Jul 1, 1977·The Journal of Experimental Medicine·S B Halstead, E J O'Rourke
Jul 1, 1983·Archives of Disease in Childhood·D IsaacsM R MacNaughton
Jun 19, 2001·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·A Osterhaus
Jul 3, 2003·Trends in Cell Biology·Gary D BaderCharles Boone
Nov 18, 2003·The British Journal of Dermatology·Donna Bilu, D N Sauder
Aug 20, 2005·Nature Reviews. Cancer·William G Kaelin
Jan 21, 2006·Respirology : Official Journal of the Asian Pacific Society of Respirology·Hongying MoNanshan Zhong
Dec 3, 2008·Handbook of Experimental Pharmacology·Wolf Peter HofmannStefan Zeuzem
Dec 26, 2008·International Journal of Antimicrobial Agents·Erik De Clercq
Jun 17, 2009·Cell Host & Microbe·Marisa K Isaacson, Hidde L Ploegh
Jan 6, 2010·EMBO Molecular Medicine·Ana M Mendes-PereiraAlan Ashworth
Apr 7, 2010·Annual Review of Biochemistry·Stephanie MohrNorbert Perrimon
Dec 3, 2010·Journal of Leukocyte Biology·Mònica ComaladaJordi Xaus
Dec 15, 2010·Trends in Biochemical Sciences·Norman E DaveyToby J Gibson
Apr 5, 2011·Cell·Alan AshworthJorge S Reis-Filho
May 13, 2011·Nature·Yang-Yu LiuAlbert-László Barabási
Nov 10, 2011·Molecular Systems Biology·Murat CokolFrederick P Roth
Jan 21, 2012·Bioorganic & Medicinal Chemistry·Kerry AndrusiakCharles Boone
Mar 1, 2012·Molecular & Cellular Proteomics : MCP·Laurène Meyniel-SchicklinVincent Lotteau
Jul 5, 2012·PLoS Computational Biology·Natali GulbahceAlbert-László Barabási
Apr 9, 2013·Nature·Samir BhattSimon I Hay
Nov 13, 2013·Nature Reviews. Microbiology·Rachel L GrahamRalph S Baric
Sep 17, 2014·The Journal of Cell Biology·Fred D MastJohn D Aitchison
Nov 5, 2014·Nature Methods·Peter C FridyMichael P Rout
Jan 17, 2015·Genome Medicine·Benoît de ChasseyVincent Lotteau
Apr 8, 2015·Antimicrobial Agents and Chemotherapy·Dandan LiuStefan G Sarafianos
May 23, 2015·Molecular Cell·Nevan J KroganTrey Ideker

❮ Previous
Next ❯

Citations

Jun 3, 2021·Pathogens·Martin A Prusinkiewicz, Joe S Mymryk
Jul 2, 2021·Chemical Reviews·Kamalakannan VijayanAlexis Kaushansky

❮ Previous
Next ❯

Methods Mentioned

BETA
x-ray crystallography
gene knockouts
glycosylation

Related Concepts

Related Feeds

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

Current Topics in Microbiology and Immunology
Geneviève F Desrochers, John Paul Pezacki
PLoS Computational Biology
Natali GulbahceAlbert-László Barabási
Proceedings of the National Academy of Sciences of the United States of America
David WangJoseph L DeRisi
© 2021 Meta ULC. All rights reserved